ngTMA® and Ultivue!

 ngTMA® partner with Ultivue  to promote multiplexed immunofluorescence (mIF) assays and the use of next generation TMAs to unlock spatial analysis in clinical and translational research.

Ultivue develops unique solutions for use in mIF applications, imaging, and spatial phenomics. Its proprietary InSituPlex® technology enabling improved signal to noise data is designed for fast and comprehensive exploration of biologically relevant targets, up to 12-plex, with same slide-H&E analysis in tissue samples combines the power of computational pathology & spatial biology to guide translational science in immuno-oncology.

More information here: https://www.businesswire.com/news/home/20220929005039/en/Ultivue-and-ngTMA%C2%AE-Announce-Collaborative-Agreement-to-Provide-Multiplex-and-Spatial-Analysis-for-Clinical-Research